FDA Inspection
BloodworksBloodworks – FDA Inspection, Nov 27, 2012
Record Details
This FDA Inspection record concerns Bloodworks, with an inspection on November 27, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Bloodworks
- Inspection Date
- November 27, 2012
- Product Type
- Biologics
View Company Profile
ID · df7dc789-7c42-4691-a4d0-0b2a87e10097
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 808145
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bloodworks
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 15, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 7, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 2, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 28, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Bloodworks
- FDA Inspection 1326732 - 2026-07-15
- FDA Inspection 1158755 - 2021-12-07
- FDA Inspection 981627 - 2016-08-02
- FDA Inspection 895415 - 2014-09-12
- FDA Inspection 815837 - 2013-01-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.